![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/spacer.gif)
epirubicin hydrochloride![Patient Information Patient Information](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/btn-patient-info.gif) The hydrochloride salt of the 4'-epi-isomer of the anthracycline antineoplastic antibiotic doxorubicin. Epirubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/spacer.gif)
Synonyms: | ![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/spacer.gif) | 4'-epiadriamycin 4'-epidoxorubicin 4'-epi-doxorubicin HCl epi-ADR epidoxorubicin pidorubicin | | ![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/spacer.gif) | US brand name: | ![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/spacer.gif) | Ellence | | ![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/spacer.gif) | Foreign brand name: | ![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/spacer.gif) | Pharmorubicin PFS | | ![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/spacer.gif) | Abbreviations: | ![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/spacer.gif) | 4'-epi DX EPI epi DX | | ![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/spacer.gif) | Code name: | ![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/spacer.gif) | IMI-28 | | ![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/spacer.gif) | Chemical structure names: | ![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/spacer.gif) | - (8S-cis)-10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione hydrochloride
- (8S-cis)-10-[(-amino-2,3,6-trideoxy-alpha-L-arabino-hexpyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxacetyl)-1-methoxy-5,12-naphthacenedione hydrochloride
- 3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside hydrochloride
| | ![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090509182536im_/http://www.cancer.gov/images/spacer.gif) |